In case PRCA is diagnosed, therapy with Nespo must be discontinued and patients should not be switched to another recombinant erythropoietic protein (see section 4.4).
PRCA diagnoosimisel tuleb ravi Nespo’ ga katkestada ning patsiente ei tohi üle viia teisele rekombinantsele erütropoetiinproteiinile (vt lõik 4. 4).